Imricor Medical Systems, Inc. Stock

Equities

IMR

AU0000054942

Advanced Medical Equipment & Technology

Market Closed - Australian S.E. 02:10:46 2024-04-30 am EDT 5-day change 1st Jan Change
0.495 AUD +1.02% Intraday chart for Imricor Medical Systems, Inc. +3.12% -13.16%
Sales 2024 * 3.81M 5.84M Sales 2025 * 8.74M 13.39M Capitalization 65.1M 99.73M
Net income 2024 * -14M -21.45M Net income 2025 * -11M -16.85M EV / Sales 2024 * 14 x
Net cash position 2024 * 11.7M 17.92M Net cash position 2025 * 13.7M 20.99M EV / Sales 2025 * 5.88 x
P/E ratio 2024 *
-4.87 x
P/E ratio 2025 *
-6.3 x
Employees -
Yield 2024 *
-
Yield 2025 *
-
Free-Float 62.1%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.02%
1 week+3.12%
Current month-11.61%
1 month-7.48%
3 months-19.51%
6 months-21.43%
Current year-13.16%
More quotes
1 week
0.48
Extreme 0.48
0.52
1 month
0.48
Extreme 0.48
0.60
Current year
0.42
Extreme 0.42
0.63
1 year
0.26
Extreme 0.26
0.84
3 years
0.11
Extreme 0.105
2.10
5 years
0.11
Extreme 0.105
2.94
10 years
0.11
Extreme 0.105
2.94
More quotes
Managers TitleAgeSince
Chief Executive Officer 56 05-12-31
Director of Finance/CFO - 19-12-31
Chief Tech/Sci/R&D Officer - 20-04-30
Members of the board TitleAgeSince
Director/Board Member - 21-02-28
Director/Board Member 58 19-04-30
Director/Board Member 57 14-08-31
More insiders
Date Price Change Volume
24-04-30 0.495 +1.02% 89 290
24-04-29 0.49 0.00% 5,000
24-04-26 0.49 -2.00% 55,367
24-04-24 0.5 +4.17% 61,146
24-04-23 0.48 -7.69% 27,606

Delayed Quote Australian S.E., April 30, 2024 at 02:10 am EDT

More quotes
Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.
Calendar
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3214 USD
Average target price
0.616 USD
Spread / Average Target
+91.65%
Consensus

Annual profits - Rate of surprise